By Healthcare Dive Staff
Published May 8, 2026
In a strategic move to navigate an increasingly volatile legislative landscape, the Federation of American Hospitals (FAH) has appointed industry veteran Elizabeth Schwartz as its new Senior Vice President and Head of Government Relations. Schwartz, who joins the national trade association after a decade-long tenure leading U.S. policy and advocacy initiatives at biopharmaceutical giant Merck, assumes the role at a critical inflection point for the American healthcare sector.
As for-profit hospital systems face a "perfect storm" of federal funding reductions, expiring subsidies, and shifting reimbursement models, the FAH is aggressively fortifying its presence on Capitol Hill. Schwartz’s appointment signals a shift toward a more sophisticated, high-level advocacy strategy as the organization seeks to protect the interests of its approximately 1,000 member hospitals.
The Strategic Shift: An Overview of the Appointment
The appointment of Elizabeth Schwartz represents a calculated pivot for the FAH. By pulling leadership from the biopharmaceutical sector—an industry well-versed in navigating complex regulatory environments and high-stakes patent litigation—the FAH aims to bring a new level of rigor to its engagement with federal policymakers.
Schwartz’s primary mandate is to lead the FAH’s advocacy efforts with both lawmakers and key stakeholders. Her expertise in the policy-making process is expected to be instrumental as the organization pushes back against policies that threaten the financial viability of tax-paying, for-profit health systems. Her career at Merck, where she successfully maneuvered through the intricacies of Medicare Part D and drug pricing legislation, provides her with a unique toolkit to address the specific challenges facing the hospital industry today.
"She understands not only the policy landscape, but also the political dynamics that shape it—an increasingly important combination in today’s environment," said Charlene MacDonald, President and CEO of the FAH, in a statement released Thursday.
Chronology: The Path to Increased Advocacy
The decision to elevate the government relations office comes after a period of steadily increasing political spending and intensified lobbying activity. The trajectory of the FAH’s influence efforts can be traced back to the turbulent post-pandemic period, where fiscal instability became the new normal.
- 2022–2023: The FAH began a strategic internal assessment of its lobbying footprint, recognizing that the post-COVID-19 environment would necessitate more aggressive engagement on reimbursement rates.
- 2024: The association increased its frequency of testimony before the House Ways and Means Committee and the Senate Finance Committee, focusing on the rising costs of labor and medical supplies.
- 2025: A record-setting year for the FAH. Federal disclosures indicate the group spent $3.6 million on lobbying, its highest expenditure since 2019. This investment allowed the FAH to scale its legislative monitoring team and expand its reach into state-level policy discussions.
- May 2026: Elizabeth Schwartz is formally appointed to oversee this expanded apparatus, tasked with translating the organization’s growing financial investment into concrete legislative victories.
Supporting Data: The Financial Context of the Healthcare Sector
The urgency behind the FAH’s recruitment efforts is rooted in a series of harsh financial realities facing hospital systems. Data from the past eighteen months illustrates why the industry is currently on a war footing.
The Medicaid Contraction
Under the Trump administration, federal oversight has shifted toward stricter fiscal discipline within the Medicaid program. Recent policy changes have effectively reduced billions of dollars in funding for safety-net hospitals. This is compounded by new federal guidance that restricts how states can manage "state-directed payments," a vital source of revenue that helped offset the losses incurred by treating a high volume of Medicaid patients.
The ACA Subsidy Cliff
Perhaps the most damaging blow to hospital revenue streams has been the expiration of enhanced subsidies for Affordable Care Act (ACA) plans. When Congress allowed these expanded subsidies to lapse, the immediate impact was a decline in enrollment. For many large, for-profit health systems, the shift meant a direct hit to net patient service revenue. Reports indicate that major players, such as HCA Healthcare, reported losses in the hundreds of millions of dollars directly attributable to the lapse in coverage, as patients either shifted to less profitable plans or opted out of insurance entirely, leading to a spike in uncompensated care.
Official Responses and Strategic Vision
In her first official statement following the announcement, Schwartz emphasized the need for a narrative shift. She suggested that the industry’s advocacy must move beyond defensive posturing to proactively defining the value proposition of for-profit hospitals.
"At a time when affordability and transparency are front and center in health care discussions, we have an important story to tell about how taxpaying hospitals are increasing access, advancing innovation, and working to make care more affordable for patients," Schwartz noted.
Charlene MacDonald, who has been instrumental in the FAH’s recent restructuring, echoed this sentiment. By bringing in leadership from outside the traditional hospital lobby—specifically from the pharmaceutical world—MacDonald is signaling that the FAH intends to engage in a broader, more integrated dialogue regarding the total cost of care.
Implications: A High-Stakes Future for Hospitals
The implications of this appointment extend far beyond the hiring of a new executive. The healthcare industry is currently in a defensive crouch, and the battle lines for the remainder of the 2026 legislative session are clearly drawn.
1. Regulatory Turbulence
The most immediate implication is the potential for increased conflict with the Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS). With the FAH now armed with more aggressive leadership, hospital systems are likely to challenge proposed rule changes regarding price transparency and site-neutral payment policies with greater legal and lobbying force.
2. The Battle for State-Directed Payments
As states face their own budget constraints, the fight over Medicaid supplemental payments will remain a top priority. Schwartz will likely focus her initial months on building a coalition of state hospital associations to lobby Congress for a "fix" to the current restrictive payment policies, which many analysts argue are crippling the ability of safety-net providers to maintain operations in rural and underserved urban areas.
3. Consolidation and Market Power
The political environment is increasingly hostile toward hospital consolidation. As the FAH lobbies for more funding, they will face significant pushback from lawmakers who blame industry consolidation for rising costs. Schwartz’s ability to navigate these political dynamics—balancing the need for financial stability with the demand for transparency—will be the ultimate test of her leadership.
4. Long-Term Financial Viability
The long-term implication is whether the for-profit hospital model can survive in its current form. With thin margins becoming thinner, the industry is looking to the FAH to secure a legislative "floor" that prevents further erosion of government-backed revenue. Whether the FAH can influence a legislative environment that is increasingly focused on cutting the federal deficit remains the central question of the year.
As Elizabeth Schwartz settles into her office at the Federation of American Hospitals, the eyes of the healthcare industry will be upon her. The challenges she faces are systemic, political, and deeply entrenched. However, her appointment is a clear signal that the FAH is not prepared to accept a future of diminished federal support without a significant fight. The coming months will determine if this new advocacy strategy is enough to stave off the fiscal pressures threatening the nation’s hospital infrastructure.
